Turn Therapeutics Inc. (TTRX)

NASDAQ: TTRX · Real-Time Price · USD

3.700

+0.155 (4.37%)

Apr 27, 2026, 4:00 PM EDT - Market closed

Turn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	110	116	-	-	-
Enterprise Value	105	113	-	-	-
Last Close Price	3.70	3.94	-	-	-
PB Ratio	23.25	24.75	-	-	-
P/TBV Ratio	29.28	30.82	-	-	-
Debt / Equity Ratio	0.02	0.02	-0.68	0.29	0.07
Net Debt / Equity Ratio	-1.07	-1.07	4.24	-13.48	-1.75
Net Debt / EBITDA Ratio	0.79	0.79	0.43	0.51	0.49
Quick Ratio	0.85	0.85	1.23	2.41	1.22
Current Ratio	0.87	0.87	1.55	2.45	1.23
Return on Equity (ROE)	-141.67%	-141.67%	-	-369.43%	-
Return on Assets (ROA)	-55.90%	-55.90%	-55.30%	-58.56%	-
Return on Capital Employed (ROCE)	-103.20%	-103.20%	-134.00%	-151.50%	-353.90%
Earnings Yield	-2.90%	-2.75%	-	-	-
Buyback Yield / Dilution	-4.03%	-4.03%	-0.56%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q